MP07-11 EFFICACY OF FESOTERODINE TO AMELIORATE AUTONOMIC DYSREFLEXIA IN PATIENTS WITH SPINAL CORD INJURY SUFFERING FROM NEUROGENIC DETRUSOR OVERACTIVITY

INTRODUCTION AND OBJECTIVES: Botulinum toxin is already well established as a second line therapy for the overactive detrusor, despite several drawbacks, which include an increased cost and the potential for more severe complications compared to antimuscarinics. Our study aims to investigate whether giving antimuscarinics after the toxin injection might increase the interval between intravesical treatments.